Article Information
History
- October 19, 2017.
Article Versions
- Version 1 (October 17, 2017 - 14:43).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aymen A. Elfiky1,2,3, MD, MOH, MSc, MBA,
- Maximilian J. Pany2,3, BA,
- Ravi B. Parikh2,3, MD, MPP and
- Ziad Obermeyer2,3,4, MD, MPhil
- 1Dana-Farber Cancer Institute, Boston, MA
- 2Harvard Medical School, Boston, MA
- 3Brigham and Women’s Hospital, Boston, MA
- 4Ariadne Labs, Brigham and Women’s Hospital and Harvard School of Public Health, Boston, MA
- Correspondence to: Ziad Obermeyer, MD, MPhil Neville House, 75 Francis St Boston, MA 02115 Email: zobermeyer{at}bwh.harvard.edu Phone: 617-525-3133
Posted October 19, 2017.
A machine learning approach to predicting short-term mortality risk in patients starting chemotherapy
